Financhill
Back

EyePoint Pharmaceuticals Vs. Avidity Biosciences Industry Stock Comparison

Sell
32

EYPT
EyePoint Pharmaceuticals

Last Price:
$6.25
Seasonality Move:
16.96%
Sell
25

RNA
Avidity Biosciences

Last Price:
$30.84
Seasonality Move:
0%
Sell
32
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $6.23. The Score for EYPT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $30.84. The Score for RNA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $6.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight buying pressure.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $30.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing slight buying pressure.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 43.36 Sell
Chaikin Money Flow: 342001 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6 - 6.88) Sell
Bollinger Bands (100): (6.39 - 9.79) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 48.83 Sell
Chaikin Money Flow: 549842 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.62 - 32.34) Sell
Bollinger Bands (100): (29.04 - 41.76) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.51 Sell
20-day SMA: 6.45 Sell
50-day SMA: 7 Sell
200-day SMA: 8.51 Sell
8-day EMA: 6.4 Sell
20-day EMA: 6.54 Sell
50-day EMA: 6.97 Sell
200-day EMA: 9.15 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.69 Sell
20-day SMA: 30.67 Buy
50-day SMA: 31.11 Sell
200-day SMA: 38.69 Sell
8-day EMA: 31.19 Sell
20-day EMA: 31.15 Sell
50-day EMA: 32.04 Sell
200-day EMA: 33.88 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.96 per share, and a decrease next year of $0.48 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):